ADIM
HQY icon

Alpha DNA Investment Management’s HealthEquity HQY Stock Holding History

Alpha DNA Investment Management’s Portfolio HQY Stock Details HQY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-12,613
Closed -$796K – 195
2023
Q2 		$796K Buy
+12,613
New +$731K 0.27% 98

Other funds holding HQY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Alpha DNA Investment Management's HQY Position: Q3 2023 in Review

Alpha DNA Investment Management sold out of HealthEquity (HQY) in Q3 2023, closing a stake of 12,613 shares — an estimated $796K sold.

Alpha DNA Investment Management first reported a position in HQY in Q2 2023 and held it in 1 quarter. The position peaked at $796K in Q2 2023. 342 funds tracked by Wall St. Rank hold HQY as of Q3 2023.

  • Alpha DNA Investment Management reported no remaining HealthEquity position as of Q3 2023 after selling out during the quarter.
  • Alpha DNA Investment Management sold 12,613 HealthEquity shares in Q3 2023, an estimated $796K.
  • Alpha DNA Investment Management first reported a position in HealthEquity in Q2 2023 and held it in 1 quarter.
  • Alpha DNA Investment Management's HealthEquity position peaked at $796K in Q2 2023.
  • 342 funds tracked by Wall St. Rank held HealthEquity as of Q3 2023.

Based on Alpha DNA Investment Management's 13F filing for Q3 2023, filed 7 Nov 2023.